Cresco Labs Inc.
CRLBF
$0.80
-$0.02-2.28%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -4.95% | -9.46% | -9.46% | -8.62% | -7.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.95% | -9.46% | -9.46% | -8.62% | -7.50% |
| Cost of Revenue | -5.69% | -9.83% | -7.95% | -4.21% | -6.73% |
| Gross Profit | -4.21% | -9.08% | -10.94% | -12.88% | -8.26% |
| SG&A Expenses | 3.63% | -4.70% | -2.49% | -0.61% | 0.39% |
| Depreciation & Amortization | 8.41% | -7.27% | -7.31% | -21.38% | -21.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.59% | -7.75% | -5.86% | -3.61% | -4.75% |
| Operating Income | -28.04% | -20.57% | -29.65% | -34.32% | -22.77% |
| Income Before Tax | -739.66% | -254.05% | -798.86% | -512.08% | 112.33% |
| Income Tax Expenses | -83.03% | -3.60% | -10.53% | -17.70% | 72.72% |
| Earnings from Continuing Operations | -209.39% | -92.52% | -131.52% | 9.64% | 77.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 225.23% | 177.69% | 133.24% | 86.49% | 12.71% |
| Net Income | -120.93% | -60.20% | -81.91% | 22.60% | 73.51% |
| EBIT | -28.04% | -20.57% | -29.65% | -34.32% | -22.77% |
| EBITDA | -21.18% | -18.57% | -25.42% | -29.53% | -21.03% |
| EPS Basic | -116.59% | -54.55% | -75.65% | 24.23% | 74.34% |
| Normalized Basic EPS | 108.65% | 198.73% | 224.57% | 231.01% | 175.35% |
| EPS Diluted | -114.24% | -56.17% | -77.46% | 22.23% | 73.57% |
| Normalized Diluted EPS | 107.89% | 198.73% | 224.57% | 231.01% | 175.35% |
| Average Basic Shares Outstanding | 3.62% | 3.12% | 2.76% | 2.54% | 2.69% |
| Average Diluted Shares Outstanding | 10.87% | 3.12% | 2.76% | 2.54% | 2.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |